Atlas Trials

Pharmacokinetics and Safety of Evogliptin in Subjects With Hepatic Dysfunction

Clinical trial NCT02754219 · COMPLETED

Trial details

NCT number
NCT02754219
Sponsor
Dong-A ST Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Liver Dysfunction
Start date
2016-09-22
Primary completion
2018-01-19
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.